Hypercholesterolaemia in aged patients. To treat or not to treat? - Suppr | 超能文献

Hypercholesterolaemia in aged patients. To treat or not to treat?

作者信息

Tikkanen M J, Tilvis R S

机构信息

First Department of Medicine, University of Helsinki, Finland.

出版信息

Drugs Aging. 1991 Nov-Dec;1(6):427-30. doi: 10.2165/00002512-199101060-00002.

DOI:10.2165/00002512-199101060-00002

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Hypercholesterolaemia in aged patients. To treat or not to treat?

Drugs Aging. 1991 Nov-Dec;1(6):427-30. doi: 10.2165/00002512-199101060-00002.

2

When to treat hypercholesterolaemia.

Med Clin (Barc). 2024 Mar 8;162(5):238-243. doi: 10.1016/j.medcli.2023.09.001. Epub 2023 Nov 2.

3

Management of hypercholesterolaemia and cholestyramine.

N Z Med J. 1984 Apr 25;97(754):272.

4

Ispaghula husk in the treatment of hypercholesterolaemia: a double-blind controlled study.

J Cardiovasc Risk. 1998 Jun;5(3):167-72.

5

Cholestyramine and hypercholesterolaemia.

Br Med J. 1968 Mar 9;1(5592):629.

6

[Clinical assessment of probucol and its therapeutical effect on hypercholesterolaemia (author's transl)].

Cas Lek Cesk. 1981 Jul 9;120(27):832-5.

7

Hypercholesterolaemia--a problem solved?

N Z Med J. 1987 Mar 11;100(819):135.

8

Management of hypertension and hypercholesterolaemia in primary care in The Netherlands.

Curr Med Res Opin. 2005 Jun;21(6):839-48. doi: 10.1185/030079905X46368.

9

The cost of simvastatin therapy in treatment of hypercholesterolaemia in a hospital lipid clinic.

Med J Aust. 1992 Apr 6;156(7):510.

10

Could saponins be a useful treatment for hypercholesterolaemia?

Eur J Clin Nutr. 1990 Jan;44(1):79-88.

引用本文的文献

1

Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease.

Pharmacoeconomics. 1992 Feb;1(2):124-45. doi: 10.2165/00019053-199201020-00009.

2

HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.

Drugs Aging. 1992 Nov-Dec;2(6):518-29. doi: 10.2165/00002512-199202060-00007.

本文引用的文献

1

Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology.

J Chronic Dis. 1982 Feb;35(2):101-14. doi: 10.1016/0021-9681(82)90111-4.

2

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

JAMA. 1984 Jan 20;251(3):351-64. doi: 10.1001/jama.1984.03340270029025.

3

High-density lipoprotein cholesterol levels of very old people in the diagnosis of dementia.

Age Ageing. 1986 Sep;15(5):267-70. doi: 10.1093/ageing/15.5.267.

4

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

JAMA. 1986 Nov 28;256(20):2823-8.

5

Cholesterol and mortality. 30 years of follow-up from the Framingham study.

JAMA. 1987 Apr 24;257(16):2176-80. doi: 10.1001/jama.257.16.2176.

6

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Arch Intern Med. 1988 Jan;148(1):36-69.

7

The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.

Eur Heart J. 1988 May;9(5):571-600.

8

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001.

9

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

Acta Med Scand. 1988;223(5):405-18. doi: 10.1111/j.0954-6820.1988.tb15891.x.

10

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.

N Engl J Med. 1989 Apr 6;320(14):904-10. doi: 10.1056/NEJM198904063201405.